Eyra Copenhagen IVS: Financial statements 2019
CVR: 40290109
Source: annual report 2019, Danish Business Authority
25/02/2019 – 31/12/2019
Eyra Copenhagen IVS (CVR 40290109) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 152,787,330 and a net result of DKK -28,100,333. The profit margin was -18.4%. Equity in the 2019 report amounted to DKK 0.
- Revenue
- DKK 152,787,330
- Gross Profit
- DKK -28,100,333
- Profit/Loss
- DKK -28,100,333
- Equity
- DKK 0
- Total Assets
- DKK 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
On October 7, 2019, the company changed its name from CBD Copenhagen IVS to Eyra Copenhagen IVS.
As of February 25, 2019, David Beran is registered as adm. dir. of Eyra Copenhagen IVS.
Eyra Copenhagen IVS was founded on February 25, 2019.
About Eyra Copenhagen IVS
Eyra Copenhagen IVS was a Danish company of the type Iværksætterselskab based in Frederiksberg, founded in 2019. The company has been dissolved on 15 December 2023. The company was registered under the industry Detailhandel med medicin og produkter til personlig pleje via internet. The company was previously named CBD Copenhagen IVS. The company has 1 employee (2020). In 2020, the company reported a gross profit of DKK 39,737 and a net result of DKK 39,737 compared with DKK -28,100,333 the year before. Equity in the 2020 report amounted to DKK 0.
